These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

71 related articles for article (PubMed ID: 11347073)

  • 1. [Anderson's disease/chylomicron retention disease].
    Ohashi K
    Nihon Rinsho; 2001 Mar; 59 Suppl 3():261-5. PubMed ID: 11347073
    [No Abstract]   [Full Text] [Related]  

  • 2. [Hypo beta-lipoproteinemia with selective deletion of apo B-48].
    Tohdoh Y; Mabuchi H
    Ryoikibetsu Shokogun Shirizu; 1998; (19 Pt 2):39-40. PubMed ID: 9645003
    [No Abstract]   [Full Text] [Related]  

  • 3. [Familial hypobetalipoproteinemia].
    Kinoshita M
    Nihon Rinsho; 2001 Mar; 59 Suppl 3():254-7. PubMed ID: 11347070
    [No Abstract]   [Full Text] [Related]  

  • 4. Anderson's disease: genetic exclusion of the apolipoprotein-B gene in two families.
    Pessah M; Benlian P; Beucler I; Loux N; Schmitz J; Junien C; Infante R
    J Clin Invest; 1991 Jan; 87(1):367-70. PubMed ID: 1985110
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Using genetically engineered mice to understand apolipoprotein-B deficiency syndromes in humans.
    Raabe M; Kim E; Véniant M; Nielsen LB; Young SG
    Proc Assoc Am Physicians; 1998; 110(6):521-30. PubMed ID: 9824535
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anderson's disease: no linkage to the apo B locus.
    Strich D; Goldstein R; Phillips A; Shemer R; Goldberg Y; Razin A; Freier S
    J Pediatr Gastroenterol Nutr; 1993 Apr; 16(3):257-64. PubMed ID: 8492252
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chylomicron retention disease--the role of ultrastructural examination in differential diagnosis.
    Boldrini R; Biselli R; Bosman C
    Pathol Res Pract; 2001; 197(11):753-7. PubMed ID: 11770019
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Receptor-ligand interactions in the hepatic uptake of chylomicron remnants studied with genetically manipulated mice.
    Redgrave TG; Mortimer BC; Martins IJ
    Z Gastroenterol; 1996 Jun; 34 Suppl 3():105-7. PubMed ID: 8767480
    [No Abstract]   [Full Text] [Related]  

  • 9. [Anderson's disease (steatorrhea due to the retention of chylomicrons): diagnostic criteria].
    Oltra Benavent M; Chirivella Casanova M; Pereda Pérez A; Ribes Konickx C; Ferrer Calvete J
    An Esp Pediatr; 1997 Aug; 47(2):195-8. PubMed ID: 9382356
    [No Abstract]   [Full Text] [Related]  

  • 10. [Normotriglyceridemic abetalipoproteinemia].
    Ohashi K
    Nihon Rinsho; 2001 Mar; 59 Suppl 3():258-60. PubMed ID: 11347071
    [No Abstract]   [Full Text] [Related]  

  • 11. Apolipoprotein B48 glycosylation in abetalipoproteinemia and Anderson's disease.
    Berriot-Varoqueaux N; Dannoura AH; Moreau A; Verthier N; Sassolas A; Cadiot G; Lachaux A; Munck A; Schmitz J; Aggerbeck LP; Samson-Bouma ME
    Gastroenterology; 2001 Nov; 121(5):1101-8. PubMed ID: 11677202
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Apolipoprotein B-48 as a marker for chylomicrons and their remnants: studies in the postprandial state.
    Isherwood SG; Williams CM; Gould BJ
    Proc Nutr Soc; 1997 Mar; 56(1B):497-505. PubMed ID: 9168557
    [No Abstract]   [Full Text] [Related]  

  • 13. Mental retardation and ataxia due to normotriglyceridemic hypobetalipoproteinemia.
    Homer VM; George PM; du Toit S; Davidson JS; Wilson CJ
    Ann Neurol; 2005 Jul; 58(1):160-3. PubMed ID: 15984016
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Familial defective apolipoprotein B-100].
    Nohara A; Mabuchi H
    Ryoikibetsu Shokogun Shirizu; 1998; (19 Pt 2):41-5. PubMed ID: 9645004
    [No Abstract]   [Full Text] [Related]  

  • 15. Vitamin E deficiency due to chylomicron retention disease in Marinesco-Sjögren syndrome.
    Aguglia U; Annesi G; Pasquinelli G; Spadafora P; Gambardella A; Annesi F; Pasqua AA; Cavalcanti F; Crescibene L; Bagalà A; Bono F; Oliveri RL; Valentino P; Zappia M; Quattrone A
    Ann Neurol; 2000 Feb; 47(2):260-4. PubMed ID: 10665502
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interrelationships between human apolipoprotein A-I and apolipoproteins B-48 and B-100 kinetics using stable isotopes.
    Welty FK; Lichtenstein AH; Barrett PH; Dolnikowski GG; Schaefer EJ
    Arterioscler Thromb Vasc Biol; 2004 Sep; 24(9):1703-7. PubMed ID: 15242863
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Postprandial apolipoprotein B48-and B100-containing lipoproteins in type 2 diabetes: do statins have a specific effect on triglyceride metabolism?
    Battula SB; Fitzsimons O; Moreno S; Owens D; Collins P; Johnson A; Tomkin GH
    Metabolism; 2000 Aug; 49(8):1049-54. PubMed ID: 10954025
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Familial hypo beta-lipoproteinemia].
    Tohdoh Y; Mabuchi H
    Ryoikibetsu Shokogun Shirizu; 1998; (19 Pt 2):29-32. PubMed ID: 9645000
    [No Abstract]   [Full Text] [Related]  

  • 19. An apolipoprotein(a) peptide delays chylomicron remnant clearance and increases plasma remnant lipoproteins and atherosclerosis in vivo.
    Devlin CM; Lee SJ; Kuriakose G; Spencer C; Becker L; Grosskopf I; Ko C; Huang LS; Koschinsky ML; Cooper AD; Tabas I
    Arterioscler Thromb Vasc Biol; 2005 Aug; 25(8):1704-10. PubMed ID: 15905467
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Postprandial hyperlipemia and coronary artery disease.
    Nakamura H; Ikewaki K; Nishiwaki M; Shige H
    Ann N Y Acad Sci; 1995 Jan; 748():441-6. PubMed ID: 7695187
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.